MedPath

Omegapharm

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

TGA:9

Drug Approvals

MITOMYCIN OMEGAPHARM mitomycin powder for injection 2mg vial (243552)

Product Name
MITOMYCIN OMEGAPHARM mitomycin powder for injection 2mg vial
Approval Date
Mar 8, 2016
TGA

MITOMYCIN ACCORD mitomycin powder for injection 2mg vial (243572)

Product Name
MITOMYCIN ACCORD mitomycin powder for injection 2mg vial
Approval Date
Mar 8, 2016
TGA

MITOMYCIN OMEGAPHARM mitomycin powder for injection 20mg vial (243554)

Product Name
MITOMYCIN OMEGAPHARM mitomycin powder for injection 20mg vial
Approval Date
Mar 8, 2016
TGA

MITOMYCIN ACCORD mitomycin powder for injection 10mg vial (243592)

Product Name
MITOMYCIN ACCORD mitomycin powder for injection 10mg vial
Approval Date
Mar 8, 2016
TGA

MITOMYCIN ACCORD mitomycin powder for injection 20mg vial (243612)

Product Name
MITOMYCIN ACCORD mitomycin powder for injection 20mg vial
Approval Date
Mar 8, 2016
TGA

MITOMYCIN OMEGAPHARM mitomycin powder for injection 10mg vial (243553)

Product Name
MITOMYCIN OMEGAPHARM mitomycin powder for injection 10mg vial
Approval Date
Mar 8, 2016
TGA

OMEGAPHARM THIOPENTAL SODIUM 470 mg thiopental sodium 470 mg powder for injection vial (209478)

Product Name
OMEGAPHARM THIOPENTAL SODIUM 470 mg thiopental sodium 470 mg powder for injection vial
Approval Date
Nov 10, 2015
TGA

OMEGAPHARM ACETYLCYSTEINE acetylcysteine 2000 mg/ 10 mL solution for inhalation vial (180343)

Product Name
OMEGAPHARM ACETYLCYSTEINE 2000 mg/ 10 mL acetylcysteine solution for inhalation vial
Approval Date
Feb 28, 2011
TGA

OMEGAPHARM ACETYLCYSTEINE acetylcysteine 800 mg/ 4 mL solution for inhalation vial (172101)

Product Name
OMEGAPHARM ACETYLCYSTEINE 800 mg/4 mL acetylcysteine solution for inhalation vial
Approval Date
Feb 28, 2011
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.